Trials / Sponsors / Panbela Therapeutics, Inc.
Panbela Therapeutics, Inc.
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV | Phase 2 / Phase 3 | 2022-08-08 |
| Completed | Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer Pancreatic Cancer Metastatic, Pancreatic Cancer Stage IV, Stage IV Pancreatic Cancer | Phase 1 | 2018-06-04 |
| Completed | Study of SBP-101 in Pancreatic Cancer Pancreatic Cancer, Ductal Adenocarcinoma of the Pancreas | Phase 1 | 2016-01-01 |